NuVasive Eyes Cervical Spine to Drive Future Growth

NuVasive logo

NuVasive reported 4Q20 orthopedic revenue of USD $291.8 million, -6% vs. 4Q19 with full-year 2020 revenue of $1 billion, -10.1% vs. 2019. The company enjoyed relatively stable case volumes through mid-December, but COVID’s second wave brought significant disruption through year-end, particularly in the U.S. and Europe. NuVasive expects...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us